Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5140395 | 0.89 | MAPT (0.46) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5048668 | 0.88 | SMN1; SMN2 (0.41) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL389643 | 0.85 | MAPT (0.45) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL388754 | 0.85 | MAPT (0.44) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL390184 | 0.82 | MAPT (0.45) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5188843 | 0.79 | SMN1; SMN2 (0.38) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL1906181 | 0.78 | MAPT (0.40) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL1906183 | 0.76 | MAPT (0.45) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5189238 | 0.76 | GPR119 (0.40) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL5577991 | 0.75 | MAPT (0.40) | MAPTMAPK1TDP1SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1758565-A2 | COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL | Arena Pharmaceuticals, Inc. (US) | 2007-03-07 | — | — | EP | disclosed |
| WO-2006076231-A2 | COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL | ARENA PHARMACEUTICALS, INC. (US) | 2006-07-20 | — | — | WO | disclosed |